About Proneness Pharmaceuticals Private Limited
Data last updated:
Proneness Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2017PTC098396. Its GSTIN is 09AAJCP5142L1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.5 Lakh. It is led by directors Rajendra Singh and Beena Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Gata No 356 New Basti Tarahiya, Lucknow, Uttar Pradesh, India – 226203.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹7.68 Lakh (net margin 3.7%) and EBITDA of ₹14.87 Lakh (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 213% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pronenesspharma.com.
Company details
Contact details
Proneness Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is pronenesspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGround Floor Gata No 356 New Basti Tarahiya, Lucknow, Uttar Pradesh, India – 226203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Proneness Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Proneness Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Proneness Pharmaceuticals Private Limited, buy the company report.
Financials of Proneness Pharmaceuticals Private Limited
FY 2025 filings availableProneness Pharmaceuticals Private Limited reported revenue of ₹2.09 Cr (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 213% over five years, including 38% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Proneness Pharmaceuticals Private Limited, buy the company report.
Board of directors of Proneness Pharmaceuticals Private Limited
Proneness Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Singh | Director | 07 Nov 2017 | 9 Years 0 Months | Current |
| Beena Singh | Director | 07 Nov 2017 | 9 Years 0 Months | Current |
Auditor
Proneness Pharmaceuticals Private Limited is audited by R J C P SUBHASH MISRA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R J C P SUBHASH MISRA & CO | FY 2021 | 007415C |
Shareholding
The shareholding of Proneness Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Proneness Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Proneness Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Proneness Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Proneness Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCP5142L1Z0 | Uttar Pradesh | Active | 25 Dec 2017 |
To see the full GST registrations and return filing status of Proneness Pharmaceuticals Private Limited, buy the company report.
Recent activity
Proneness Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Beena Singh was appointed as Director on 07 Nov 2017.
Frequently asked questions
Proneness Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 November 2017 (9+ years old) and is registered under CIN U74999UP2017PTC098396.
Proneness Pharmaceuticals has 2 current directors:
- Rajendra Singh - Director
- Beena Singh - Director
The latest financial statements of Proneness Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Proneness Pharmaceuticals is 09AAJCP5142L1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Proneness Pharmaceuticals is U74999UP2017PTC098396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proneness Pharmaceuticals was incorporated on 07 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Beena Singh was appointed as Director on 07 Nov 2017. Rajendra Singh was appointed as Director on 07 Nov 2017.
Proneness Pharmaceuticals can be reached through the website pronenesspharma.com. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Proneness Pharmaceuticals is at Ground Floor Gata No 356 New Basti Tarahiya, Lucknow, Uttar Pradesh, India – 226203.
Proneness Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
